Brief: Wai Chun Bio Technology Sees Loss Attributable Ranging From HK$19 Mln To HK$25 Mln For Eighteen Months
Nov 8 (Reuters) - Wai Chun Bio Technology Ltd 0660.HK :
* SEES LOSS ATTRIBUTABLE RANGING FROM HK$19 MILLION TO HK$25
MILLION FOR EIGHTEEN MONTHS
* EXPECTED INCREASE IN LOSS DUE TO INCREASE IN INTEREST
EXPENSES
ON CONVERTIBLE BONDS
Further company coverage: 0660.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wai Chun Bio Technology
See all newsBrief: Wai Chun Bio Technology Says Unable To Publish FY2026 Annual Results By Sept 30
Brief: Wai Chun Bio Technology Enters MoU For Ai Digital Infrastructure Project In Malaysia
Brief: Wai Chun Bio Technology Appointed Exclusive Overseas Master Agent For Crane And Mining Equipment Globally
Brief: Wai Chun Bio Technology Signs MoU For Strategic Cooperation On New Energy Projects
Brief: Wai Chun Bio Technology Receives Judgment From Hong Kong High Court Against Co, Wai Chun Group